Free Trial

Axon Enterprise (AXON) Stock Forecast & Price Target

Axon Enterprise logo
$742.75 +0.43 (+0.06%)
As of 04:00 PM Eastern

Axon Enterprise - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
1
Buy
10

Based on 12 Wall Street analysts who have issued ratings for Axon Enterprise in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 1 has given a sell rating, 1 has given a hold rating, and 10 have given a buy rating for AXON.

Consensus Price Target

$652.73
-12.12% Downside
According to the 12 analysts' twelve-month price targets for Axon Enterprise, the average price target is $652.73. The highest price target for AXON is $830.00, while the lowest price target for AXON is $380.00. The average price target represents a forecasted downside of -12.12% from the current price of $742.75.
Get the Latest News and Ratings for AXON and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Axon Enterprise and its competitors.

Sign Up

AXON Analyst Ratings Over Time

TypeCurrent Forecast
5/20/24 to 5/20/25
1 Month Ago
4/20/24 to 4/20/25
3 Months Ago
2/20/24 to 2/19/25
1 Year Ago
5/21/23 to 5/20/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
10 Buy rating(s)
14 Buy rating(s)
11 Buy rating(s)
Hold
1 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$652.73$626.45$542.15$335.27
Forecasted Upside-12.12% Downside11.96% Upside-8.64% Downside14.81% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

AXON Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AXON Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Axon Enterprise Stock vs. The Competition

TypeAxon EnterpriseAerospace CompaniesS&P 500
Consensus Rating Score
2.75
2.77
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-11.95% Downside26.10% Upside12.75% Upside
News Sentiment Rating
Positive News

See Recent AXON News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/14/2025The Goldman Sachs Group
3 of 5 stars
Michael Ng
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$730.00 ➝ $830.00+15.56%
5/9/2025Barclays
3 of 5 stars
Tim Long
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$726.00 ➝ $735.00+6.83%
5/8/2025Needham & Company LLC
2 of 5 stars
Joshua Reilly
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$600.00 ➝ $750.00+24.93%
3/10/2025Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Hamblin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Cautious
2/19/2025Northcoast Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Housum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
2/4/2025JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform
1/8/2025TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Sherman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$700.00+24.55%
12/6/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$600.00 ➝ $800.00+15.98%
12/3/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight$500.00 ➝ $700.00+10.00%
11/11/2024Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$365.00 ➝ $550.00-10.13%
7/17/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$380.00+18.96%
7/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$385.00+20.53%
4/24/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
4/11/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$330.00 ➝ $365.00+14.69%
3/13/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$380.00+22.04%
11/8/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$223.00 ➝ $233.00+7.69%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:31 AM ET.


Should I Buy Axon Enterprise Stock? AXON Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, May 16, 2025. Please send any questions or comments about these Axon Enterprise pros and cons to contact@marketbeat.com.

Axon Enterprise
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Axon Enterprise, Inc.:

  • The current stock price is around $728, reflecting a strong market position and investor confidence in the company's growth potential.
  • Axon Enterprise, Inc. reported a significant year-over-year revenue increase of over 31%, indicating robust demand for its products and services.
  • The company has a healthy net margin of 15.37%, suggesting efficient operations and profitability, which can lead to higher returns for investors.
  • With a market capitalization exceeding $56 billion, Axon Enterprise, Inc. is well-positioned in the biotechnology sector, attracting institutional investors and enhancing stability.
  • The firm has consistently outperformed earnings expectations, with recent earnings per share surpassing analyst estimates, showcasing strong financial performance.

Axon Enterprise
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Axon Enterprise, Inc. for these reasons:

  • The price-to-earnings (P/E) ratio is quite high at around 188, which may indicate that the stock is overvalued compared to its earnings, posing a risk for potential investors.
  • Despite strong revenue growth, the company's return on equity is relatively modest at 7.50%, which may suggest that it is not utilizing its equity as effectively as some competitors.
  • Axon Enterprise, Inc. has a beta of 1.24, indicating that its stock price is more volatile than the market, which could lead to higher risk for investors.
  • Institutional investors hold a significant portion of the stock (over 79%), which can lead to increased volatility if these investors decide to sell their positions.
  • The company operates in a competitive biotechnology market, which may pose challenges in maintaining its growth trajectory and market share against emerging competitors.

AXON Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Axon Enterprise is $652.73, with a high forecast of $830.00 and a low forecast of $380.00.

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last twelve months. There is currently 1 sell rating, 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AXON shares.

According to analysts, Axon Enterprise's stock has a predicted downside of -12.12% based on their 12-month stock forecasts.

Over the previous 90 days, Axon Enterprise's stock had 3 downgrades by analysts.

Axon Enterprise has been rated by research analysts at Barclays, Craig Hallum, Needham & Company LLC, Northcoast Research, and The Goldman Sachs Group in the past 90 days.

Analysts like Axon Enterprise less than other "aerospace" companies. The consensus rating score for Axon Enterprise is 2.75 while the average consensus rating score for "aerospace" companies is 2.77. Learn more on how AXON compares to other companies.


This page (NASDAQ:AXON) was last updated on 5/20/2025 by MarketBeat.com Staff
From Our Partners